133
Views
3
CrossRef citations to date
0
Altmetric
CLINICAL FEATURES   Original Research

Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis

, , , , , , & show all
Pages 529-534 | Received 26 Mar 2015, Accepted 01 May 2015, Published online: 15 May 2015

References

  • Simpson G , Judge DJ . Management of malignant pleural effusion. Respirology 2015;20:169
  • Thomas JM , Musani AI . Malignant pleural effusions: a review. Clin Chest Med 2013;34:459–71
  • Egan AM , McPhillips D , Sarkar S , Breen DP . Malignant pleural effusion. QJM 2014;107:179–84
  • Ruckdeschel JC . Management of malignant pleural effusions. Semin Oncol 1994;22:58–63
  • Villena Garrido V , Cases Viedma E , Fernández Villar A , de Pablo Gafas A , Pérez Rodríguez E , Porcel Pérez JM , et al. Recommendations of diagnosis and treatment of pleural effusion Update. Arch Bronconeumol 2014;50:235–49
  • Maskell NA , Gleeson FV , Davies RJ . Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003;361:1326–30
  • Shi HZ , Liang QL , Jiang J , Qin XJ , Yang HB . Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology 2008;13:518–27
  • Liang QL , Shi HZ , Qin XJ , Liang XD , Jiang J , Yang HB . Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 2008;63:35–41
  • Shen YC , Liu MQ , Wan C , Chen L , Wang T , Wen FQ . Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis. Exp Ther Med 2012;3:1072–6
  • Economidou F , Margaritopoulos G , Antoniou KM , Siafakas NM . The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications. Exp Ther Med 2010;1:3–7
  • Folkman J . Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. Exp Cell Res 2006;312:594–607
  • Skovseth DK , Veuger MJ , Sorensen DR , De Angelis PM , Haraldsen G . Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood 2005;105:1044–51
  • Whiting PF , Weswood ME , Rutjes AW , Reitsma JB , Bossuyt PN , Kleijnen J . Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006;6:9
  • Shen Y , Zhu H , Wan C , Chen L , Wang T , Yang T , Wen F . Can cholesterol be used to distinguish pleural exudates from transudates? evidence from a bivariate meta-analysis. BMC Pulm Med 2014;14:61
  • Sumi M , Kagohashi K , Satoh H , Ishikawa H , Funayama Y , Sekizawa K . Endostatin levels in exudative pleural effusions. Lung 2003;181:329–34
  • Zhang Y , Li S . Diagnostic value of detecting endostatin levels of pleural effusions for lung cancer (Chinese). Shi Yong Lin Chuang Yi Yao Za Zhi 2006;10:22–4
  • Zhou W , Bai M , Jin Y . Diagnostic value of VEGF and endostatin for tuberculous pleural effusion and malignant pleural effusion (Chinese). Zhong Hua Jie He Hu Xi Za Zhi 2008;31:139–40
  • Yang Y , Sun X , Qu Y . Diagnostic value of VEGF and endostatin for malignant pleural effusions (Chinese). Zhong Hua Zhong Liu Fang Zhi Za Zhi 2009;16:1312–14
  • Zhou WB , Bai M , Jin Y . Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions. Int J Tuberc Lung Dis 2009;13:381–6
  • Li XB , Li BL , Shi GL . Clinical significance of matrix metalloproteinase-9 and endostatin in differential diagnosis of benign and malignant pleural effusion (Chinese). Zhong Hua Jie He Hu Xi Za Zhi 2011;34:310–11
  • Zhang Y , Yu LK , Xia N . Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion. Asian Pac J Trop Med 2012;5:239–42
  • Li Q , Wang YB , Yang YM . The differential diagnostic value of combined detection of endostatin, carcinoembryonic antigen, and tumor-specific growth factor in benign and malignant pleural effusions (Chinese). Lin Chuang Fei Ke Za Zhi 2013;18:688–9
  • Rodriguez-Panadero F , Romero-Romero B . Current and future options for the diagnosis of malignant pleural effusion. Expert Opin Med Diagn 2013;7:275–87
  • Chen Y , Liang B , Zhao YJ , Wang SC , Fan YB , Wu GP . Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer. Diagn Cytopathol 2012;40:287–91
  • Zhang Y , Yu LK , Lu GJ , Xia N , Xie HY , Hu W , et al. Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer. Asian Pac J Cancer Prev 2014;15:8435–40
  • Zhao WY , Chen DY , Chen JH , Ji ZN . Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites. Cell Biochem Biophys 2014;70:623–8
  • Glas AS , Lijmer JG , Prins MH , Bonsel GJ , Bossuyt PM . The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003;56:1129–35
  • Higgins JP , Thompson SG . Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.